NHGRI will fund pilot studies using innovative molecular technologies, beyond standard DNA sequencing, to identify genes or variants causing rare genetic disorders, with applications opening in 2026.
This upcoming grant will fund projects to develop, curate, and share valuable genomic resources for the research community, supporting both basic and clinical genomics.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
This upcoming NHLBI grant will offer small grants to current or recent career development awardees to help them advance their research and transition toward independent funding.
NIH grant supports specific research projects aligned with NIH Institutes' missions, but excludes clinical trials.